Sign in
Enrolling by invitationNo phase

Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies

Key facts

Who runs it
Ruihua Wei
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
60 people, planned
Started
20 Sept 2025
Expected to end
31 Dec 2026
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Eyerising RS-200-2A
  • Eyerising SLX-1A
Record updated
29 October 2026

Who can take part

Age
18 years to 35 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • 18-35 years old, gender not limited; Obtained informed consent

Who cannot take part

  • Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)
  • With congenital eye disease, such as congenital cataract, congenital retinal disease
  • Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)
  • Refractive medium opacity (such as corneal disease, crystal opacity, etc.)
  • Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases
  • Obvious strabismus and amblyopia
  • Bnormal intraocular pressure and clinical significance (IOP <10 mmHg or IOP>21mmHg or binocular IOP difference ≥5mmHg)
  • Optic nerve damage or congenital optic nerve dysfunction
  • Can not be regularly checked
  • The adjustment range is less than 8D or obvious near difficulties
  • Other reasons researchers think it is not suitable for inclusion in researchers

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 35 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light

The 3 groups in the trial

  • The Laser GroupTreatment being tested

    Use Eyerising (RS-200-2A), 1 time,2 times or 3 times a day

    Treatment: Eyerising RS-200-2A

  • The LED GroupTreatment being tested

    Use Eyerising(SLX-1A), 2 times a day

    Treatment: Eyerising SLX-1A

  • ControlNo study treatment, for comparison

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Study on the Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies for Adult Myopia Treatment
Criteria questions
Built from NCT07186088, who can take part
Record updated
29 October 2026